Wake up! comparte diariamente en Linkedin, una pequeña selección de noticias publicadas por diferentes Medios de Comunicación y Blogs de la Red: Ideas, proyectos, negocios, startups, empresas,.. Euskadi, Semana del 28 de febrero,...Read more
Today Columbus Venture Partners announces the creation of Syngoi Technologies, a biotechnology company engaged in the production of synthetic DNA through a new enzymatic process, owned by the company, that addresses the needs of advanced therapies where DNA is the fundamental starting material. This is the case of gene therapy and mRNA-based vaccines, emerging therapeutic strategies where manufacturing is an important bottleneck. Syngoi has its own technology for the manufacture of its optimised synthetic DNA (orDNATM) which confers multiple...Read more
Síguenos y recibe en tu Linkedin información diaria segmentada
por sectores de actividad y países de interés para tomar las
decisiones más competitivas
Latest innovations and first-hand business models